Last updated: Sep 21, 2026, 12:42 PM UTC
Latest Insider Sales $25K+
Browse the latest insider trading activity on the sell side with a total transaction size of $25,000 or more, reported in SEC Form 4 filings. The most recent is a Tempus AI, Inc. (TEM) evp, chief legal officer's sale of 2,951 shares, valued at about $221,325. Alongside the dollar amount, you can see how much each sale changed the insider's holdings. Use the color tags and SEC filing links to check for employee stock plans, dividend reinvestment, and prearranged trades among the insider trading activity.
These filings are deferred by 6 hours & limited to 50 category trades. Sign up for real time updates and 20 years of data.
View Latest Alerts
Notable Patterns
Latest Cluster Buys
Latest Penny Stock Buys
Biggest Buys This Week
Biggest Buys This Month
Latest Insider Trading - All Filings
Latest Insider Purchases
Latest Insider Purchases $25K+
Latest Insider Purchases $100K+
Latest Officer Purchases $25K+
Latest Officer Purchases $100K+
Latest CEO/CFO Purchases $25K+
Latest CEO/CFO Purchases $100K+
Latest Insider Sales
Latest Insider Sales $25K+
Latest Insider Sales $100K+
Latest Officer Sales $25K+
Latest Officer Sales $100K+
Latest CEO/CFO Sales $25K+
Latest CEO/CFO Sales $100K+
Loading alerts
50 trades of 40883 total
| File Date | Date of Earliest Transaction | Date of Latest Transaction | Ticker Symbol | Company | Insider Name | Insider Title | Buy/Sell | Transaction Count | Shares Transacted | Price | Total Transaction Value | Total Shares Owned After Transaction | Position Size Change | SEC Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-17 | TEM | Tempus Ai, Inc. | Polovin Andrew | EVP, Chief Legal Officer | Sell | 1 | 2,951 | $75.00 | $221,325.00 | 135,189 | 2.14% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-17 | TEM | Tempus Ai, Inc. | Bartolucci Ryan M | Chief Accounting Officer | Sell | 1 | 7,062 | $75.00 | $529,650.00 | 60,804 | 10.41% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | TEM | Tempus Ai, Inc. | Fukushima Ryan | CEO, Data | Sell | 1 | 700 | $70.00 | $49,000.00 | 15,874 | 4.22% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-18 | HTFL | Heartflow, Inc. | Verghese Vikram | Chief Financial Officer | Sell | 2 | 24,345 | $50.55 | $1,230,742.00 | 155,183 | 13.56% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-18 | DSP | Viant Technology Inc. | Madden Larry | Chief Financial Officer | Sell | 2 | 31,644 | $12.33 | $390,019.35 | 342,711 | 8.45% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | DUOL | Duolingo, Inc. | Von Ahn Luis | President & CEO, Co-Founder | Sell | 2 | 28,292 | $150.22 | $4,250,140.67 | 0 | 100.00% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | ADPT | Adaptive Biotechnologies Corp | Lo Francis | Chief People Officer | Sell | 2 | 115,406 | $28.06 | $3,238,004.07 | 220,867 | 34.32% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | CORT | Corcept Therapeutics Inc | Vieira Roberto Wandenkolk | President, Oncology | Sell | 1 | 296 | $100.82 | $29,842.72 | 3,946 | 6.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-09 | 2026-09-09 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | Sell | 1 | 35,994 | $18.46 | $664,550.02 | 88,033 | 29.02% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-18 | CSHR | Coinshares Plc | Masters Daniel | Director, 10% Owner | Sell | 3 | 182,370 | $5.08 | $926,202.52 | 21,610,245 | 0.84% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-16 | 2026-09-16 | SNAP | Snap Inc | Mohan Ajit | Chief Business Officer | Sell | 1 | 6,797 | $5.82 | $39,575.53 | 4,965,300 | 0.14% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-17 | MARA | Mara Holdings, Inc. | Khan Salman Hassan | Chief Financial Officer | Sell | 1 | 16,000 | $11.45 | $183,200.00 | 551,681 | 2.82% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | BE | Bloom Energy Corp | Joshi Aman | Chief Commercial Officer | Sell | 1 | 3,601 | $269.94 | $972,053.94 | 155,529 | 2.26% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-10 | 2026-09-10 | PGNY | Progyny, Inc. | Gordon Kevin K | Director | Sell | 1 | 11,500 | $27.12 | $311,858.15 | 6,792 | 62.87% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-16 | 2026-09-16 | BE | Bloom Energy Corp | Kurzymski Maciej | Chief Accounting Officer | Sell | 1 | 2,295 | $268.42 | $616,023.90 | 77,391 | 2.88% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-16 | SKYE | Skye Bioscience, Inc. | Schwab Andrew J. | Director, 10% Owner | Sell | 2 | 33,892 | $1.91 | $64,733.72 | 5,616 | 85.79% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-17 | NEGG | Newegg Commerce, Inc. | Chang Fred Faching | Director, 10% Owner | Sell | 2 | 52,082 | $13.11 | $682,707.26 | 2,947,549 | 1.74% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | BE | Bloom Energy Corp | Soderberg Shawn Marie | Chief Legal Officer and Corporate Secretary | Sell | 1 | 2,870 | $270.07 | $775,100.90 | 126,500 | 2.22% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | BE | Bloom Energy Corp | Chitoori Satish | Chief Operations Officer | Sell | 1 | 2,870 | $270.06 | $775,072.20 | 202,494 | 1.40% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-17 | ADBE | Adobe Inc. | Narayen Shantanu | Chair and CEO | Sell | 12 | 125,000 | $250.76 | $31,344,876.21 | 238,724 | 34.37% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-18 | 2026-09-18 | SYNA | Synaptics Inc | Bodensteiner Lisa | The reporting person is Senior Vice President, Chief Legal Officer and Corporate Secretary | Sell | 1 | 334 | $92.63 | $30,938.42 | 77,518 | 0.43% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | KMI | Kinder Morgan, Inc. | Garthwaite Michael P. | VP (Pres., Products Pipelines) | Sell | 1 | 1,550 | $30.80 | $47,744.65 | 48,863 | 3.07% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | WSM | Williams Sonoma Inc | Howie Jeffrey | EVP CHIEF FINANCIAL OFFICER | Sell | 8 | 3,045 | $220.61 | $671,771.98 | 34,138 | 8.19% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Sandler Alan B. | Chief Development Officer | Sell | 2 | 341 | $199.24 | $67,940.67 | 52,868 | 0.64% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Mancini Anthony | Chief Global Commercialization Officer | Sell | 1 | 1,747 | $199.30 | $348,182.69 | 42,116 | 3.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | WSM | Williams Sonoma Inc | Alber Laura | PRESIDENT & CEO | Sell | 5 | 35,000 | $221.20 | $7,742,139.42 | 853,524 | 3.94% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Kelsey Stephen Michael | Senior Advisor to the Chief Executive Officer | Sell | 1 | 5,484 | $199.30 | $1,092,978.75 | 286,307 | 1.88% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Horn Margaret A | Chief Operating Officer | Sell | 1 | 4,891 | $199.30 | $974,791.95 | 149,680 | 3.16% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Goldsmith Mark A | President and Chief Executive Officer | Sell | 1 | 13,775 | $199.30 | $2,745,401.58 | 253,342 | 5.16% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Goldsmith Mark A | President and Chief Executive Officer | Sell | 1 | 213 | $195.01 | $41,536.81 | 267,117 | 0.08% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Anders Jack | Chief Financial Officer | Sell | 2 | 4,053 | $199.24 | $807,513.37 | 119,216 | 3.29% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-18 | 2026-09-18 | BX | Blackstone Inc. | Baratta Joseph | Director | Sell | 2 | 100,000 | $123.80 | $12,380,048.12 | 771,599 | 11.47% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-16 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sell | 7 | 1,457 | $166.92 | $243,203.90 | 72,433 | 1.97% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-16 | SVV | Savers Value Village, Inc. | Allen William T | Director | Sell | 1 | 26,151 | $9.22 | $241,169.75 | 28,861 | 47.54% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-18 | XYZ | Block, Inc. | Eisen Anthony Mathew | Director | Sell | 3 | 18,000 | $77.63 | $1,397,280.00 | 1,380,672 | 1.29% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-17 | PTCT | Ptc Therapeutics, Inc. | Schmertzler Michael | Director | Sell | 4 | 20,000 | $67.49 | $1,349,727.74 | 1,296,594 | 1.52% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-17 | 2026-09-17 | MCB | Metropolitan Bank Holding Corp. | Fredston Dale C | Director | Sell | 1 | 2,000 | $89.09 | $178,180.00 | 14,668 | 12.00% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-17 | 2026-09-17 | BRFH | Barfresh Food Group Inc. | Roger Lisa | Other, Former Chief Financial Officer | Sell | 1 | 25,329 | $1.10 | $27,861.90 | 46,414 | 35.31% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-18 | BNTX | Biontech Se | Sahin Ugur | Chief Executive Officer | Sell | 2 | 64,000 | $97.49 | $6,239,071.20 | 489,209 | 11.57% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-17 | 2026-09-17 | AMBA | Ambarella Inc | Wang Feng-Ming | CEO | Sell | 1 | 6,086 | $64.83 | $394,555.38 | 767,759 | 0.79% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-18 | LITE | Lumentum Holdings Inc. | Wupen Yuen | PRESIDENT, GLOBAL BUS. UNITS | Sell | 3 | 1,500 | $903.43 | $1,355,140.00 | 111,627 | 1.33% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-17 | 2026-09-17 | AMBA | Ambarella Inc | Ju Chi-Hong | Senior VP, Systems & GM | Sell | 1 | 2,009 | $64.83 | $130,243.47 | 154,153 | 1.29% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-16 | AFL | Aflac Inc | Koide Masatoshi | Pres. and Rep. Director, ALIJ | Sell | 1 | 10,000 | $118.04 | $1,180,400.00 | 76,422 | 11.57% | View filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. 2026-09-18 | 2026-09-16 | 2026-09-16 | AFL | Aflac Inc | Koide Masatoshi | Pres. and Rep. Director, ALIJ | Sell | 1 | 3,201 | $117.93 | $377,493.93 | 86,422 | 3.57% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-17 | 2026-09-17 | AMBA | Ambarella Inc | Lee Chan W | Chief Operations Officer | Sell | 1 | 2,893 | $64.83 | $187,553.19 | 154,443 | 1.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-16 | 2026-09-18 | HRMY | Harmony Biosciences Holdings, Inc. | Budur Kumar | CHIEF MEDICAL OFFICER | Sell | 3 | 38,452 | $43.05 | $1,655,416.21 | 13,115 | 74.57% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-16 | 2026-09-16 | WGS | Genedx Holdings Corp. | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | 5 | 10,501 | $97.61 | $1,025,012.87 | 115,476 | 8.34% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-09-18 | 2026-09-17 | 2026-09-17 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP & GENERAL COUNSEL | Sell | 7 | 8,300 | $497.54 | $4,129,607.97 | 45,172 | 15.52% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-09-18 | 2026-09-16 | 2026-09-16 | WGS | Genedx Holdings Corp. | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | 5 | 3,728 | $97.61 | $363,892.14 | 44,945 | 7.66% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-09-18 | 2026-09-16 | 2026-09-16 | TDW | Tidewater Inc | Robotti Robert | Director | Sell | 2 | 10,300 | $89.85 | $925,448.82 | 2,202,690 | 0.47% | View filing |
Loading alerts